mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |